GH1 and diabetes mellitus: A total of 38 incident cases of diabetes mellitus (19 type 1, 18 type 2, and 1 case with type not specified) were reported in a cohort of 21,448 patients eligible for analysis, with mean ± SD follow-up from start of GH therapy of 5.0 ± 3.5 years (107,101 PY).